These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 1715080)
21. Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol. Bruchovsky N; Goldenberg SL; Akakura K; Rennie PS Cancer; 1993 Sep; 72(5):1685-91. PubMed ID: 7688656 [TBL] [Abstract][Full Text] [Related]
22. Bone alkaline phosphatase and prostate-specific antigen in the monitoring of prostate cancer. Cooper EH; Whelan P; Purves D Prostate; 1994 Nov; 25(5):236-42. PubMed ID: 7526352 [TBL] [Abstract][Full Text] [Related]
23. Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer. Gleave ME; Goldenberg SL; Jones EC; Bruchovsky N; Sullivan LD J Urol; 1996 Jan; 155(1):213-9. PubMed ID: 7490838 [TBL] [Abstract][Full Text] [Related]
24. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1. Yang J; Tang A; Ma J; Sun X; Ming L Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773 [TBL] [Abstract][Full Text] [Related]
25. Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate. Ohio State University experience. Drago JR; Badalament RA; Wientjes MG; Smith JJ; Nesbitt JA; York JP; Ashton JJ; Neff JC Urology; 1989 Oct; 34(4):187-92. PubMed ID: 2477931 [TBL] [Abstract][Full Text] [Related]
26. Neuron-specific enolase in testicular cancer--clinical experiences with serum neuron-specific enolase in patients with testicular cancer at diagnosis and during follow-up. Tandstad T; Klepp O Acta Oncol; 2003; 42(3):202-6. PubMed ID: 12852696 [TBL] [Abstract][Full Text] [Related]
27. Chromogranin A and neurone-specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration-resistant prostate cancer undergoing abiraterone therapy. Heck MM; Thaler MA; Schmid SC; Seitz AK; Tauber R; Kübler H; Maurer T; Thalgott M; Hatzichristodoulou G; Höppner M; Nawroth R; Luppa PB; Gschwend JE; Retz M BJU Int; 2017 Jan; 119(1):30-37. PubMed ID: 27037533 [TBL] [Abstract][Full Text] [Related]
28. Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China. Song WA; Liu X; Tian XD; Wang W; Liang CY; Zhang T; Guo JT; Peng YH; Zhou NK Chin Med J (Engl); 2011 Oct; 124(20):3244-8. PubMed ID: 22088515 [TBL] [Abstract][Full Text] [Related]
29. Serum carcinoembryonic antigen, neuron-specific enolase as biomarkers for diagnosis of nonsmall cell lung cancer. Dong Y; Zheng X; Yang Z; Sun M; Zhang G; An X; Pan L; Zhang S J Cancer Res Ther; 2016 Oct; 12(Supplement):34-36. PubMed ID: 27721249 [TBL] [Abstract][Full Text] [Related]
30. Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice. Csapo Z; Brand K; Walther R; Fokas K J Urol; 1988 Nov; 140(5):1032-8. PubMed ID: 2459419 [TBL] [Abstract][Full Text] [Related]
31. Multiple marker evaluation in prostatic cancer with prostatic acid phosphatase, gamma-seminoprotein and prostate-specific antigen. Fuse H; Umeda K; Mizuno I; Katayama T Int Urol Nephrol; 1991; 23(5):455-63. PubMed ID: 1718922 [TBL] [Abstract][Full Text] [Related]
32. The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer. Wang P; Piao Y; Zhang X; Li W; Hao X Cancer Biomark; 2013; 13(2):123-30. PubMed ID: 23838141 [TBL] [Abstract][Full Text] [Related]
33. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609 [TBL] [Abstract][Full Text] [Related]
34. Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer. Barlési F; Gimenez C; Torre JP; Doddoli C; Mancini J; Greillier L; Roux F; Kleisbauer JP Respir Med; 2004 Apr; 98(4):357-62. PubMed ID: 15080079 [TBL] [Abstract][Full Text] [Related]
35. Elevated tumor markers in patients with pulmonary alveolar proteinosis. Fang SC; Lu KH; Wang CY; Zhang HT; Zhang YM Clin Chem Lab Med; 2013 Jul; 51(7):1493-8. PubMed ID: 23314555 [TBL] [Abstract][Full Text] [Related]
36. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate]. Morote Robles J; de Torres Mateos JA Arch Esp Urol; 1989; 42 Suppl 2():124-30. PubMed ID: 2484148 [TBL] [Abstract][Full Text] [Related]
37. Prostate-specific antigen as a marker of adenocarcinoma of prostate. Kellokumpu-Lehtinen P; Nurmi M; Koskinen P; Irjala K Urol Res; 1989; 17(4):245-9. PubMed ID: 2475959 [TBL] [Abstract][Full Text] [Related]
38. Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer. Jørgensen LG; Hansen HH; Cooper EH Eur J Cancer Clin Oncol; 1989 Jan; 25(1):123-8. PubMed ID: 2537729 [TBL] [Abstract][Full Text] [Related]
39. Cross-comparison of PSA and PAP values in a wide spectrum of prostate cancer conditions. Tarle M Anticancer Res; 1988; 8(4):569-72. PubMed ID: 2460018 [TBL] [Abstract][Full Text] [Related]
40. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. Oesterling JE J Urol; 1991 May; 145(5):907-23. PubMed ID: 1707989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]